Bank Of America Downgrades Gilead Sciences, Sees Possible Pricing War

By: via Benzinga
Bank of America downgraded Gilead Sciences, Inc. (NASDAQ: GILD) Monday from Buy to Underperform and cut its price target from $130 to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.